Read + Share
Westeel V, Schuette W, Urban T, Radonjic D, et al. Safety and tolerability of weekly docetaxel plus nintedanib: A phase I trial
after first-line chemotherapy failure in NSCLC. PLoS One 2023;18:e0292307.
PMID: 37847688
|
 |
|
Westeel V, Schuette W, Urban T, Radonjic D, et al. Safety and tolerability of weekly docetaxel plus nintedanib: A phase I trial
after first-line chemotherapy failure in NSCLC. PLoS One 2023;18:e0292307.
PMID: 37847688
|
|
|
|